XTend Medical Corporation (XMDC) Secures the BioHarp Patents

SUN VALLEY, CA–(Marketwire – October 22, 2010) –  XTend Medical (PINKSHEETS: XMDC), a company that specializes in delivering life changing medical technology to healthcare organizations globally, has secured the BioHarp patents as the agreement reached through mediation stated. The company released the following statement:

“XTend’s patent counsel, Knobbe, Martens, Olsen, & Bear, LLC, has successfully been able to secure the transfers of the patents associated with the BioHarp to XTend Medical. Now that the company has secured these patents, it can now move quickly to begin the commercialization of the BioHarp Medical device. The company has been in contact with several manufacturers interested in working closely with XTend to produce the BioHarp device. In addition, XTend continues to receive interest from numerous global distributors looking to bring the BioHarp into various countries for implementation into their healthcare programs wherein the BioHarp could play a large role in their future healthcare plans. In addition, veterinarian distributors in the U.S. and Europe feel the BioHarp could prove to be a valuable tool in pet care and have expressed a keen interest in working with XTend to sell and distribute the BioHarp. As the company progresses forward, exploring all of the opportunities presented for the BioHarp should assist the company in reaching its full potential in 2011 and beyond.”

About XTend Medical

XTend Medical is a company that specializes in the sales, manufacturing and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their recent acquisition of the BioHarp medical device will assist the company in becoming known as a leader in the healthcare sector globally. For further information, please contact them at [email protected] or visit their website at www.bioharpunius.com

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.